Literature DB >> 35285750

Integrating relative survival in multi-state models-a non-parametric approach.

Damjan Manevski1, Hein Putter2, Maja Pohar Perme1, Edouard F Bonneville2, Johannes Schetelig3, Liesbeth C de Wreede2.   

Abstract

Multi-state models provide an extension of the usual survival/event-history analysis setting. In the medical domain, multi-state models give the possibility of further investigating intermediate events such as relapse and remission. In this work, a further extension is proposed using relative survival, where mortality due to population causes (i.e. non-disease-related mortality) is evaluated. The objective is to split all mortality in disease and non-disease-related mortality, with and without intermediate events, in datasets where cause of death is not recorded or is uncertain. To this end, population mortality tables are integrated into the estimation process, while using the basic relative survival idea that the overall mortality hazard can be written as a sum of a population and an excess part. Hence, we propose an upgraded non-parametric approach to estimation, where population mortality is taken into account. Precise definitions and suitable estimators are given for both the transition hazards and probabilities. Variance estimating techniques and confidence intervals are introduced and the behaviour of the new method is investigated through simulations. The newly developed methodology is illustrated by the analysis of a cohort of patients followed after an allogeneic hematopoietic stem cell transplantation. The work has been implemented in the R package mstate.

Entities:  

Keywords:  Multi-state model; competing risks; mortality tables; mstate; relative survival

Mesh:

Year:  2022        PMID: 35285750      PMCID: PMC9245158          DOI: 10.1177/09622802221074156

Source DB:  PubMed          Journal:  Stat Methods Med Res        ISSN: 0962-2802            Impact factor:   2.494


  28 in total

Review 1.  Multi-state models for event history analysis.

Authors:  Per Kragh Andersen; Niels Keiding
Journal:  Stat Methods Med Res       Date:  2002-04       Impact factor: 3.021

2.  The heart of the matter: years-saved from cardiovascular and cancer deaths in an elite athlete cohort with over a century of follow-up.

Authors:  Juliana Antero-Jacquemin; Maja Pohar-Perme; Grégoire Rey; Jean-François Toussaint; Aurélien Latouche
Journal:  Eur J Epidemiol       Date:  2018-05-05       Impact factor: 8.082

3.  Tutorial in biostatistics: competing risks and multi-state models.

Authors:  H Putter; M Fiocco; R B Geskus
Journal:  Stat Med       Date:  2007-05-20       Impact factor: 2.373

4.  A multistate additive relative survival semi-Markov model.

Authors:  Florence Gillaizeau; Etienne Dantan; Magali Giral; Yohann Foucher
Journal:  Stat Methods Med Res       Date:  2015-06-07       Impact factor: 3.021

5.  Estimation and asymptotic theory for transition probabilities in Markov renewal multi-state models.

Authors:  Cristian Spitoni; Marion Verduijn; Hein Putter
Journal:  Int J Biostat       Date:  2012-08-07       Impact factor: 0.968

6.  Relative survival multistate Markov model.

Authors:  Ella Huszti; Michal Abrahamowicz; Ahmadou Alioum; Christine Binquet; Catherine Quantin
Journal:  Stat Med       Date:  2011-11-03       Impact factor: 2.373

7.  General tests of the Markov property in multi-state models.

Authors:  Andrew C Titman; Hein Putter
Journal:  Biostatistics       Date:  2022-04-13       Impact factor: 5.899

8.  Accuracy of cancer death certificates and its effect on cancer mortality statistics.

Authors:  C Percy; E Stanek; L Gloeckler
Journal:  Am J Public Health       Date:  1981-03       Impact factor: 9.308

9.  On standardized relative survival.

Authors:  Peter Sasieni; Adam R Brentnall
Journal:  Biometrics       Date:  2016-08-23       Impact factor: 2.571

10.  A hybrid landmark Aalen-Johansen estimator for transition probabilities in partially non-Markov multi-state models.

Authors:  Niklas Maltzahn; Rune Hoff; Odd O Aalen; Ingrid S Mehlum; Hein Putter; Jon Michael Gran
Journal:  Lifetime Data Anal       Date:  2021-09-30       Impact factor: 1.588

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.